Financial Year |
March 31 2022 |
Monetary Funds |
1,620,981,040.34 |
Held-for-trading Financial Assets |
463,480,837.18 |
Notes Receivable |
3,493,049.73 |
Accounts Receivable |
895,268,453.07 |
Advances to Suppliers |
113,492,429.43 |
Other Receivables |
60,076,808.40 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
5,356,369.86 |
Dividend Receivable |
-- |
Inventories |
1,302,742,370.57 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
112,332,635.33 |
Total Current Assets |
5,109,303,703.13 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
551,207,993.48 |
Investment Properties |
531,280,001.69 |
Fixed Assetes |
63,725,883.90 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
14,099,036.40 |
R&D expenses |
-- |
Goodwill |
50,365,036.62 |
Long-Term Deferred and Prepaid Expenses |
30,178,567.38 |
Deferred Income Tax Assets |
38,072,236.20 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
1,428,230,152.09 |
Total Assets |
6,537,533,855.22 |
Short-Term Loans |
770,697,026.81 |
Trading Financial liabilities |
-- |
Notes Payable |
114,600,000.00 |
Accounts Payable |
367,947,058.66 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
222,098,250.49 |
Taxes Payable |
33,616,372.32 |
Interest Payable |
-- |
Dividend Payable |
128,458.40 |
Other payables |
207,048,987.04 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
242,269,764.70 |
Other Current Liabilities |
179,442,003.73 |
Sub-Total of Current Liabilities |
2,767,506,936.61 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
51,716,389.00 |
Deferred Income Tax Liabilities |
4,493,892.96 |
Other Non-Current Liabilities |
613,210.41 |
Sub-Total of Non-Current Liabilities |
74,616,773.96 |
Total Liabilities |
2,842,123,710.57 |
Paid-In Capital(Or Share Stock) |
941,081,805.00 |
Capital Surplus |
1,389,072,830.32 |
Surplus Reserve |
159,467,001.63 |
LESS:Treasury Stock |
27,011,864.00 |
Undistributed Profits |
1,026,089,987.61 |
Minority Stockholder's Interest |
184,771,010.24 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,510,639,134.41 |
Owner's Equity(Stockholder's Equity) |
3,695,410,144.65 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
6,537,533,855.22 |